Tenax Therapeutics Inc. logo

Tenax Therapeutics Inc.

TENX | NASDAQ
Chart Builder DCF Calculator
$1.94
+$0.06 (+3.19%)
At close: Sep 22, 2026, 4:00 PM ET
$1.94
$0 (0.00%)
After-hours: Sep 22, 2026, 7:51 PM ET

Market Data

Market Cap
$49.87M
Enterprise Value
$-68.11M
Beta
0.93
Average Volume
3.59M
Shares Outstanding (Diluted)
50.87M
Shares Change YoY
28.55%
Institutional Ownership
46.93%
Exchange
NASDAQ
ISIN
US88032L6056

Price Performance

Price Change 1M
8.7%
Price Change 3M
-86.2%
Price Change 6M
-86.6%
Price Change YTD
-83.0%
Price Change 1Y
-70.8%
Price Change 3Y
-91.8%
Price Change 5Y
-99.9%
1M CAGR (ann.)
-86.0%
1Y CAGR (ann.)
-70.7%
5Y CAGR (ann.)
-76.1%
All-Time CAGR
-49.1%

Valuation

PE Ratio
-1.26
Forward PE
N/A
PEG Ratio
0.03
Forward PEG
2.36
PS Ratio
N/A
Forward PS
3.90
PB Ratio
0.44
P/FCF Ratio
-1.08
P/Adj. FCF Ratio
-1.15
P/OCF Ratio
-2.09
EV/Sales
N/A
EV/EBIT
1.45
EV/EBITDA
1.45
EV/FCF
1.48
Earnings Yield
-79.3%
FCF Yield
-92.3%
Adj. FCF Yield
-87.1%

Financial Health

Net Cash
$117.98M
Total Debt
$0
Cash & Short-Term Investments
$117.98M
Total Assets
$121.66M
Current Ratio
15.07
Quick Ratio
15.07
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
0.00
Altman Z-Score
-1.06
Piotroski F-Score
1

Margins & Profitability

Gross Profit Margin
0.0%
Operating Profit Margin
0.0%
EBITDA Margin
0.0%
Net Profit Margin
0.0%
FCF Margin
N/A
Adj. FCF Margin
N/A
SBC / Revenue
0.0%
SBC Impact (per share)
-5.6%

Returns

Return on Assets
-53.3%
Return on Equity
-61.5%
Return on Invested Capital
-60.4%
Return on Capital Employed
-60.4%
Return on Tangible Assets
-53.3%

Historical Growth (CAGR)

Revenue CAGR 3Y
N/A
Revenue CAGR 5Y
N/A
Revenue CAGR 10Y
-54.5%
EPS CAGR 3Y
126.4%
EPS CAGR 5Y
84.5%
EPS CAGR 10Y
38.1%
FCF CAGR 3Y
-67.1%
FCF CAGR 5Y
-40.5%
FCF CAGR 10Y
-16.3%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
9
EPS Growth Next 3Y
-1.3%
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 10, 2026
EPS Estimate (next Q)
-$0.35
EPS Growth Est (next Q)
-12.5%
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$4.40
Price Target Upside
134.0%

Cash Flow

Operating Cash Flow
$-46.03M
Free Cash Flow
$-46.03M
Adj. Free Cash Flow
$-43.45M
FCF Per Share
-$0.90
OCF Per Share
-$0.90
OCF/S Ratio
0.0%

Income Statement

Revenue
$0
Gross Profit
$0
Operating Income
$-49.83M
EBITDA
$-47.06M
Net Income
$-64.86M
EPS (Diluted)
-$1.49
Revenue / Employee
N/A
Profit / Employee
$-4.32M
Employees
15

© 2026 bestshares.com. All rights reserved.